发明名称 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF DISEASE TRANSMITTED BY TUMOR NECROSIS FACTOR |
摘要 |
PROBLEM TO BE SOLVED: To obtain the subject composition for treatment or prevention of diseases transmitted by tumor necrosis factor(TNF), in particular TNF- transmitted septic shock, arthritis and adult respiratory distress syndromes by including a recombinant TNF inhibitor having a specific amino acid sequence. SOLUTION: This composition contains a recombinant TNF inhibitor having an amino acid sequence shown by the formula and composed of a 30 kDa inhibitor containing a nonnaturally occurring cysteine residue in the 105th amino acid residue. It is preferable to administer the TNF inhibitor at a dose of 150 mg/kg-body weight/24 h at intervals of 3 h. It is also preferable to continue the administration for at least 24 h. The TNF inhibitor can be bound to a repeated polymer component. Polyethylene glycol is the preferable polymer component. It is preferable to administer the composition parenterally by infection. |
申请公布号 |
JPH11199505(A) |
申请公布日期 |
1999.07.27 |
申请号 |
JP19980295988 |
申请日期 |
1998.09.10 |
申请人 |
SYNERGEN INC |
发明人 |
CARMICHAEL DAVID F;SMITH CHRISTOPHER G;ROBERT C THOMPSON;RUSSELL DEBORAH;KOHNO TADAHIKO |
分类号 |
A61K38/00;A61K31/00;A61K38/02;A61K38/16;A61K47/34;A61P1/00;A61P9/00;A61P11/00;A61P11/16;A61P19/00;A61P19/02;A61P29/00;A61P31/00;A61P31/04;A61P37/00;A61P43/00;C07K14/525;C07K14/715;C12P21/00;C12P21/02 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|